Price of non-human primates drops in China following Covid boom
Drug Discovery World
MAY 1, 2024
A drop in the prices of non-human primates (NHPs) in China indicates a post-pandemic slowdown in Chinese drug development, according to a report in the Financial Times. Investment in China’s healthcare sector fell from $31 billion in 2021 to $12 billion last year, according to UBS research. The figures are taken from UBS data.
Let's personalize your content